Touzeau, C
Moreau, P
Dumontet, C
Article History
Received: 7 November 2016
Revised: 14 January 2017
Accepted: 6 February 2017
First Online: 17 February 2017
Competing interests
: PM participates in advisory boards and receives honoraria from Takeda, Janssen, Celgene, BMS and Novartis. CD participates in advisory boards or has received honoraria from IDD Biotech, Janssen, Sanofi, Inventiva and has received research funding from Roche. CT declare no conflict of interest.